New Delhi, July 3 -- Pharma stocks have a positive long-term outlook due to rising healthcare demand, an ageing population, increasing lifestyle diseases, and growth in domestic as well as global medicine markets.

Indian pharmaceutical companies may benefit from expansion in generic drugs, specialty medicines, contract manufacturing, and exports.

Let us consider the future prospects for Cipla stocks in the next three years. However, readers should note that this is not a recommendation on the stock in any form.

Cipla is one of India's leading pharmaceutical companies with a strong presence in respiratory, cardiovascular, anti-infective, and chronic therapies.

Founded in 1935, the company has built a global footprint across more than 1...